Phospholipase D signaling in ischemic heart

Area of Science:

• Cardiology
• Biochemistry
• Cell Biology

Background:

• Phospholipase D (PLD) is an enzyme involved in cell signaling.
• Myocardial ischemia and reperfusion can lead to significant cellular damage.
• The role of PLD in the context of cardiac ischemia-reperfusion injury is not fully understood.

Purpose of the Study:

• To investigate the activity and role of Phospholipase D (PLD) in rat myocardial cells during ischemia and reperfusion.
• To determine the signaling pathway involving PLD-generated products like phosphatidic acid (PtdOH) and diacylglycerol (DG).
• To explore the potential therapeutic benefits of modulating PLD activity in ischemic hearts.

Main Methods:

• In vitro and in vivo assays to measure PLD activity in rat myocardial cells and whole hearts.
• Use of radiolabeled substrates ([1-14C]arachidonic acid) to track lipid metabolism.
• Pharmacological inhibition of DG kinase and PtdOH phosphohydrolase to elucidate lipid signaling pathways.
• Assessment of cardiac functional recovery and cellular injury markers (LDH, CK) following PLD stimulation.

Main Results:

• PLD activity significantly increased in myocardial cells and whole hearts after ischemia/reperfusion.
• Ischemia/reperfusion led to elevated levels of PtdOH and DG, with DG levels increasing substantially.
• Inhibition studies indicated that PLD generates PtdOH, which is partially converted to DG.
• Stimulation of PLD with sodium oleate improved functional recovery and reduced cellular injury markers during reperfusion.

Conclusions:

• PLD is activated during myocardial ischemia-reperfusion, contributing to intracellular PtdOH and DG generation.
• PLD-mediated signaling appears to play a protective role, enhancing functional recovery and attenuating injury.
• Targeting PLD may represent a novel therapeutic strategy for managing ischemic heart conditions.